Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

Share this page:

Title

Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

Description

During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people.

Creator

Date Last Updated (Year-Month-Day)

2021-08-18

Duration

59:40 minutes

Alternate URL

https://www.youtube.com/watch?v=KkGj2FSasK0

Player